- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Abemaciclib
Total 220 results
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingEndometrial Endometrioid AdenocarcinomaUnited States
-
Boehringer IngelheimCompletedNeoplasms | Breast NeoplasmsUnited States, Spain, Korea, Republic of, Finland, Japan, Denmark, France
-
Eli Lilly and CompanyCompletedBreast Neoplasms | Neoplasm MetastasisIndia
-
Eli Lilly and CompanyCompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive TumorUnited States, Canada, Korea, Republic of, Italy, Austria, Belgium, Germany, Netherlands, Spain, Taiwan
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Eli Lilly and CompanyRecruitingBreast Neoplasms | Neoplasm MetastasisJapan, United States, China, Czechia, Belgium, Brazil, Germany, Netherlands, Russian Federation, Ukraine, Taiwan, France, Korea, Republic of, Italy, Spain, Australia, Turkey, India, Argentina, Greece, Austria, Mexico
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Non Small Cell Lung CancerUnited States, Spain, France, Belgium, Italy, Taiwan, Turkey
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnBreast Cancer
-
Indus Hospital and Health NetworkCompletedHemodynamic Stability Post Intubation in Laryngoscopy SurgeryPakistan
-
National Cancer Institute (NCI)RecruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian CarcinomaUnited States
-
Eli Lilly and CompanyActive, not recruitingProstate CancerNetherlands, United States, China, Australia, Japan, Spain, Korea, Republic of, Denmark, Germany, France, Romania
-
Dana-Farber Cancer InstituteEli Lilly and Company; Effector TherapeuticsRecruitingOvarian Cancer | Endometrial CancerUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
Eli Lilly and CompanyCompleted
-
AstraZenecaNot yet recruiting
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
Praful Ravi, MB BCHir, MRCPEli Lilly and Company; BayerActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate CancerUnited States
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
Jonsson Comprehensive Cancer CenterEli Lilly and CompanyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial CarcinomaUnited States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Non-small Cell LungUnited States, Spain
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Poland, Portugal, United Kingdom, France, Canada, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Brazil, Colombia, Greece, Taiwan, Malaysia, Philippines, Austria, R... and more
-
Avenzo Therapeutics, Inc.Recruiting
-
Ferring PharmaceuticalsCompletedLabor, Induced | Cervical RipeningUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Colorectal Carcinoma | Metastatic Colon Adenocarcinoma | Metastatic Colorectal Carcinoma | Metastatic Rectal Adenocarcinoma | Stage III Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IIIA Colon Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Colon Cancer AJCC v8 and other conditionsUnited States
-
University of LeicesterEli Lilly and Company; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; British Lung Foundation and other collaboratorsActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Belgium, Taiwan, Australia, Korea, Republic of, Japan
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
MedSIREli Lilly and CompanyActive, not recruitingBreast Cancer MetastaticItaly, Spain, Portugal
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Helsinki University Central HospitalRecruitingSolid Tumor | Advanced Cancer | Haematological MalignancyFinland
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Dana-Farber Cancer InstituteEli Lilly and CompanyNot yet recruitingEndometrial Cancer | Recurrent Endometrial Cancer | TP53United States
-
Fudan UniversityRecruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Belgium, Italy, Australia, United Kingdom, Canada, Singapore
-
Emory UniversityNational Cancer Institute (NCI)WithdrawnPrognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast Carcinoma | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Medical College of WisconsinWithdrawnAdvanced Breast Cancer | Solid TumorUnited States
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
Eli Lilly and CompanyRecruitingAdolescent | Neoplasms | ChildUnited States, Spain, United Kingdom, Australia, Italy, Japan, Belgium, France, Germany
-
European Organisation for Research and Treatment...CompletedMyelodysplastic Syndromes | LeukemiaBelgium, Switzerland, Netherlands, Germany
-
UNICANCERRecruiting
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States
-
University of WashingtonEli Lilly and CompanyNot yet recruitingRetroperitoneal SarcomaUnited States